Stockreport

Is FDA Breakthrough Status For TSHA-102 Reshaping The Investment Case For Taysha Gene Therapies (TSHA)? [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF REVEAL trial results and protocol alignment to enable a six-month interim analysis supporting a future Biologics License Application. This combination of regulatory re [Read more]